Evaluating a Digital Cognitive Behavioral Therapy for Hazardous Alcohol Use: A Pilot Study in South Korea
Development, Feasibility, Acceptability, and Preliminary Effectiveness of a Digital Cognitive Behavioral Therapy for Hazardous Alcohol Drinking: A Single-Arm Pilot Study With Predictive Modeling in South Korea
2 other identifiers
interventional
17
1 country
1
Brief Summary
The goal of this single arm pilot study is to investigate the feasibility, acceptability and preliminary effectiveness of the mobile app SOBER; for reducing and preventing hazardous alcohol drinking. The main questions it aims to answer are:
- Feasibility: How well participants adhere to the app's lessons?
- Acceptability: Participants\' satisfaction with and perceived usefulness of the app.
- Preliminary Effectiveness: The number of days participants remain abstinent. Participants will:
- Use the mobile application SOBER, which delivers digital cognitive behavioral therapy, for four weeks.
- Wear a smartwatch to collect biometric data throughout the study.
- Visit the clinic three times: at baseline (V1), two weeks after the initial visit (V2), and four weeks after the initial visit (V3).
- Be evaluated using various questionnaires about their alcohol consumption, mood, and stress levels at each visit.
- Receive psychiatric consultation with a board-certified psychiatrist regarding their alcohol consumption, based on the data entered into the mobile app.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2023
CompletedFirst Submitted
Initial submission to the registry
July 2, 2024
CompletedFirst Posted
Study publicly available on registry
July 16, 2024
CompletedJuly 16, 2024
July 1, 2024
3 months
July 2, 2024
July 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Study completion rate
The feasibility of the intervention was assessed based on the completion rates of the study
From enrollment to the end of treatment at 4 weeks
Adherence rate
The adherence rate of educational sessions in the application
From enrollment to the end of treatment at 4 weeks
Preliminary Effectiveness
days abstinent (%) in the past two weeks
asked at baseline (V1), two weeks (V2), and four weeks (V3).
Acceptability
assessed through participant satisfaction and perceived usefulness of the app, evaluated using a Likert-scale. Participants were asked to rate their satisfaction with the app on a scale from 0 (Not satisfied at all) to 5 (Very satisfied); and usefulness of the app from 0 (Not useful at all) to 5 (Very useful).
In the end of treatment at 4 weeks
Secondary Outcomes (5)
Patient Health Questionnaire-9 (PHQ-9)
Administered at baseline (V1), two weeks (V2), and four weeks (V3).
Alcohol Use Disorders Identification Test (AUDIT) Score
Administered at baseline (V1), two weeks (V2), and four weeks (V3).
Generalized Anxiety Disorder 7-item Scale (GAD-7)
Administered at baseline (V1), two weeks (V2), and four weeks (V3).
Perceived Stress Scale (PSS)
Administered at baseline (V1), two weeks (V2), and four weeks (V3).
Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar)
Administered at baseline (V1), two weeks (V2), and four weeks (V3).
Study Arms (1)
mobile application SOBER (digital cognitive behavioral therapy)
EXPERIMENTALParticipants in this group will access to the mobile app SOBER for 4 weeks. Sober is designed to provide digitalized brief-intervention and cognitive CBT-based education for high-risk drinkers. Participants are expected to engage with the app, completing tasks such as self-monitoring (daily log function that instructs participants to record their alcohol consumption, along with changes in mood, appetite and sleep quality). The app will collect data on adherence, including diary completion rates and app login frequency. Participants were also provided with a smart watch to collect biometric data throughout the duration of the study.
Interventions
SOBER is a software application (Android) that delivers cognitive behavioral therapy (CBT) in a structured and interactive manner. It analyzes patterns in participants\' lifestyles to identify problematic behaviors related to their alcohol consumption. By providing tailored guidance and support, the app aims to help individuals make sustainable changes, ultimately reducing hazardous drinking. This approach combines the principles of CBT with the convenience and accessibility of digital technology, offering a personalized experience to support the reduction of alcohol consumption.
Eligibility Criteria
You may qualify if:
- Individuals aged between 19 and 65 years.
- Individuals classified as high-risk drinkers (hazardous drinking): Alcohol Use Disorder Identification Test (AUDIT) score of 8 or higher
- Individuals who have been admitted for treatment of alcohol use disorder no more than once.
- Individuals who are assessed to have completed detoxification treatment for alcohol.
- Individuals who own a smartphone and can independently use apps on the smartphone.
- Individuals who voluntarily agree to participate in this clinical study and have signed the consent form (or whose representative has signed the consent form).
You may not qualify if:
- individuals with active and progressive physical illnesses or a life expectancy of less than 6 months
- individuals with major psychiatric comorbidities such as schizophrenia, bipolar disorder, or major depressive disorder
- pregnant women or those planning to become pregnant during the study
- individuals who had participated in another clinical study within four weeks prior to the screening for this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance Hospital
Seoul, 03722, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Young-Chul Jung, Professor, MD, PhD
Department of Psychiatry, Yonsei University College of Medicine Severance Hospital, Yonsei University Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 2, 2024
First Posted
July 16, 2024
Study Start
May 26, 2023
Primary Completion
August 22, 2023
Study Completion
August 24, 2023
Last Updated
July 16, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share